App

Blood supply in China remains stable: official
Updated: March 15, 2021 21:39 Xinhua

BEIJING — Blood supply in China remains stable and basically meets nationwide in-clinic demand, with inventory above the security line, an official with the National Health Commission (NHC) said on March 15.

Since the beginning of the vaccination against COVID-19, the NHC has strengthened the monitoring and coordination of blood supply, and put in place a system of monitoring and reporting on a daily basis, said Chang Jile, head of the disease prevention and control bureau under the NHC.

Based on scientific studies by medical experts, the NHC has introduced a waiting period for blood donors between vaccination and blood donation, Chang said.

To ensure safety, China is conducting nucleic acid test on all in-clinic blood supply, said Chang.

Copyright© www.gov.cn | About us | Contact us

Website Identification Code bm01000001 Registration Number: 05070218

All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to www.gov.cn.

Without written authorization from www.gov.cn, such content shall not be republished or used in any form.

Mobile

Desktop

Copyright© www.gov.cn | Contact us

Website Identification Code bm01000001

Registration Number: 05070218